| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |